2007
DOI: 10.1111/j.1745-7254.2007.00581.x
|View full text |Cite
|
Sign up to set email alerts
|

Effects of (-)-stepholidine on NMDA receptors: comparison with haloperidol and clozapine

Abstract: Aim: To examine whether (-)-stepholidine (SPD) has a direct effect on the Nmethyl-D-aspartic acid receptors (NMDAR) containing the NMDA receptor subunits NR2A or NR2B and to compare its effect with those of haloperidol (Hal) and clozapine (Cloz). Methods: NMDAR was transiently expressed in human embryonic kidney 293 (HEK293) cells. Changes in intracellular calcium concentration ([Ca 2+ ] i ) induced by NMDAR activation were monitored with Fura-2 ratio imaging techniques. Results: SPD had no significant ef… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 26 publications
(45 reference statements)
0
1
0
Order By: Relevance
“…Haloperidol is a known D 2 receptor antagonist, but we must acknowledge that haloperidol can also effect non-dopaminergic neurotransmitter systems (Cobos et al, 2007;Gallagher et al, 1998;Gu et al, 2007;Kroeze et al, 2003;Schotte et al, 1993). However, it has been established that the characteristic extrapyramidal movement effects of haloperidol (and other typical neuroleptics) typically relate to its occupancy of and pharmacological action at the D 2 receptor (Farde et al, 1992;Sykes et al, 2017).…”
Section: Considerationsmentioning
confidence: 99%
“…Haloperidol is a known D 2 receptor antagonist, but we must acknowledge that haloperidol can also effect non-dopaminergic neurotransmitter systems (Cobos et al, 2007;Gallagher et al, 1998;Gu et al, 2007;Kroeze et al, 2003;Schotte et al, 1993). However, it has been established that the characteristic extrapyramidal movement effects of haloperidol (and other typical neuroleptics) typically relate to its occupancy of and pharmacological action at the D 2 receptor (Farde et al, 1992;Sykes et al, 2017).…”
Section: Considerationsmentioning
confidence: 99%